Peter M. Cuckow, MBBS, FRCS (Paeds)

• Senior Lecturer, University College London,
• The Institute of Urology,
• The Institute of Child Health
• Consultant Urologist, Great Ormond Street Hospital for
• Children, NHS Trust, London, United Kingdom

Environmental exposures in children occur by ingestion of lead from ceramics treatment 11mm kidney stone bimat 3 ml purchase amex, paint medications given to newborns bimat 3 ml with mastercard, gasoline symptoms kidney failure dogs buy bimat 3 ml with amex, or water from lead pipes medications for adhd purchase bimat 3 ml online, or having a parent who works in a high-lead environment treatment pancreatitis order on line bimat. Lead poisoning through use of herbal or traditional medicines has also been reported. Such acute poisoning leads to lead encephalopathy (headache, confusion, stupor, coma, and seizures) and in addition there is abdominal colic, hypertension, and hemolytic anemia. Chronic exposure over time also is associated with a variety of neurologic, gastrointestinal, reproductive, and hematologic complications. The spider venom also causes complementdependent intravascular hemolysis associated with cleavage of glycophorin from the red cell membrane. The peripheral smear shows extensive coarse basophilic stippling and reticulocytosis. The diagnosis of lead-related hemolysis can be made from the history of lead exposure, the physical finding of the gingival lead sulfide line, and the coarse basophilic stippling of red cells. Lead inhibits two steps in heme synthesis: d-aminolevulinic acid dehydratase and heme synthetase (or ferrochelatase). The lead-induced inhibition of ferrochetalase is responsible for the increase in free erythrocyte protoporphyrin seen in this disorder and also is the basis of a simple screening test for lead toxicity. The explanation for hemolysis in acute lead toxicity is not known for sure, but it is intriguing that the basophilic stippling seen in acute lead poisoning is similar to that found in hereditary deficiency of the enzyme pyrimidine 5-nucleotidase (P5N) (Chapter 28). In the enzyme-deficient cells, intracellular aggregates form as a consequence of impaired ribosomal degradation; these aggregates appear as basophilic stippling on Wright-stained peripheral blood smears. Of interest, the P5N enzyme is readily inactivated by heavy metals such as lead, and it has been proposed that the basophilic stippling in lead poisoning is secondary to acquired P5N deficiency. Hemolysis is seen following evenomation with most poisonous snakes including cobras,216,217 Australian king brown snakes,218 the Tunisian sawscaled (carpet) viper,219 North American rattlesnakes,220 habu snakes221(191), and the several species of Russell viper (Dabois russelli) found throughout India and the rest of Asia. Hemoglobinemia and hemoglobinuria are present, the severity of which varies with the degree of evenomation and species of snake. There are a variety of components in venom which may be contributing to hemolysis. The best studied of these is phospholipase A2, which has direct toxicity for many tissues including the red cell membrane. Apparently, the water entered the bloodstream by way of the lymphatic and venous channels opened during the operation. Hemolysis witH VeNoms Spider Bites Certain spider bites produce severe, necrotic, gangrenous lesions ("necrotic arachnidism") that may be associated with hemolytic anemia or disseminated intravascular coagulation, and occasionally renal failure. Hemoglobinuria and severe anemia are characteristic findings; spherocytes and leukocytosis are found in the blood. Thrombocytopenia also has been observed, sometimes associated with diffuse intravascular coagulation. Bee Stings Africanized honey bees (Apis mellifera) were originally a problem in Brazil225 where these bees were accidentally released in the 1950s. By 1990, they were reported in Texas and are now distributed through the United States as far north as the Canadian border. In one series, hemoglobinuria was found in 11 of 14 patients who were moderately to severely burned with more than 15% of the body surface involved in most cases. This later stage of the anemia of thermal injury is probably a form of the anemia of chronic disorders (see Chapter 41). When red cells are heated to temperatures >47°C, irreversible morphologic and functional abnormalities occur, the severity of which is related to the temperature and the duration of exposure. These changes result from irreversible denaturation of the cytoskeletal protein spectrin. The hallmark of this type of hemolysis is the fragmented red cell or schistocyte, and these cells take the form of crescents, helmets, triangles, and/or microspherocytes. Hemolytic anemias resulting from red cell fragmentation are associated with abnormalities of the heart and great vessels, diseases of small vessels, disseminated intravascular coagulation, and hypertension (Table 32. In most of these conditions hemolysis is one of many clinical findings, and usually not the major problem. Cardiac and Large Vessel abnormalities Etiology Soon after the advent of open-heart surgery came the realization that the postoperative course of some patients was complicated by the development of anemia of varying severity. The discovery of fragmented red cells as a characteristic feature of this type of anemia was made in 1961, when Sayed et al. Surgically inserted prosthetic devices, particularly heart valves, furnish the most striking examples of red cell fragmentation. Most of the prosthetic valves associated with hemolytic disease are of the aortic variety,254­257 but cases of hemolysis caused by mitral valve replacement258,259,260,262,263,264,265 unsuccessful mitral valvoplasties,266,267 and repair of ruptured chordae tendineae268 also have been reported. The use of bioprostheses has reduced the risk of hemolysis greatly, although red cell fragmentation still occurs after the insertion of porcine xenografts or bioprostheses constructed from bovine tissues. Mechanical ventricular assist devices and other similar pumpbased technologies employed as a bridge to cardiac transplantation are also associated with mechanical hemolysis. One reported example of this was the overheating of dialysis solution due to failure of thermostatic controls on the hemodialysis equipment. Schistocytes in patients with (A) thrombotic thrombocytopenic purpura, (B) disseminated intravascular coagulation, and (C) aortic valve replacement. Pathogenesis Several mechanisms may account for the intravascular nature of the hemolysis and the appearance of the characteristic fragmented cells. Direct mechanical trauma, for instance by the closure of prosthetic valves, has been postulated; it is known also to occur in other conditions, such as march hemoglobinuria. It also is unlikely that the presence of prosthetic materials per se contributes to red cell fragmentation,254,294 although Teflon that is not covered by endothelium253,276 has been found at reoperation in some patients. In all likelihood, therefore, both hemolysis and the lack of endothelialization depend on the presence of a third factor, such as turbulence. The most common feature in recorded cases of hemolysis occurring after the insertion of prosthetic devices is the existence of some form of hemodynamic defect, such as regurgitation through or around valvular prostheses254,263,270 or mitral insufficiency after Teflon patch repair of atrioventricular canal defects. Clinical Manifestations No distinctive clinical features are noted, with the exception of those related to pre-existent heart disease or cardiac surgery. The development of hemolysis sometimes coincides with severe deterioration of cardiac function because of the tear of a valve cusp or the loosening of valve attachments. When the hemolysis is clinically significant, jaundice often is obvious, but hemoglobinuria may not be detectable by the naked eye. Intravascular hemolysis also has been reported in patients with a ruptured aneurysm of the sinus of Valsalva,283 coarctation of the aorta,284 coarctation with a bicuspid aortic valve,285 and a ventricular septal defect in conjunction with a patent ductus arteriosus. Laboratory Findings the blood findings of these patients vary widely, depending on the severity of the hemolytic process. The hemoglobin level may be normal if the hemolysis is compensated, or it may be extremely low. Most cells are normocytic and normochromic, but there also are variable numbers of fragmented erythrocytes, and these are identical to the schistocytes seen in patients with microangiopathic hemolytic anemia. The number of fragmented cells apparent in the blood smear directly reflects the severity of the hemolytic process. Hemosiderinuria is present in many patients when hemoglobinuria is not detectable. A positive direct antiglobulin test is observed occasionally in a few patients with prosthetic valves301­303 and occasionally in patients with severe aortic valve disease in the absence of Incidence Clinically significant hemolytic disease is reported in 5% to 25% of patients with various types of valvular prostheses,254,287,288 usually involving replacement of defective aortic valves, and in about 5% of patients with Teflon repairs of ostium primum defects. These findings indicate a link between the deposition of platelet and fibrin thrombi and red cell fragmentation, and this is supported by histologic studies that associate hemolysis with a loose fibrin network to which red cells adhere. Similar results are obtained when nylon or glass fibers are used in artificial circuits. Connective tissue diseases characterized by vasculitis, which occasionally lead to red cell fragmentation, include lupus erythematosus320 and perhaps rheumatoid arthritis, Sjögren syndrome, and polyarteritis nodosa. Fibrin deposition and endothelial changes, including immune-complex­mediated damage of endothelial cells, are probably responsible for the red cell fragmentation that occurs in disorders characterized by the presence of circulating immune complexes. The term thrombotic microangiopathy also is used to describe syndromes characterized by hemolytic anemia with red cell fragmentation, thrombocytopenia, and thrombotic lesions in small blood vessels. Fortunately, hemolysis often is not severe and may not contribute significantly to the morbidity of the disease. As the underlying disease comes under control with appropriate therapy, the fragmentation of red cells also ceases. Other cells, moving past these trapped erythrocytes, may cause their fragmentation. Giant hemangiomas and hemangioendotheliomas Microangiopathic hemolytic anemia has been identified in patients with giant hemangiomas332,333,334 and in patients with hemangioendotheliomas of the liver. These culling and pitting functions are executed by macrophages that line reticuloendothelial sinuses of the spleen, and also the liver and bone marrow (Chapter 65). The spleen is considered to be the most stringent of the reticuloendothelial filters, and this is aided by the slow rate of blood flow through the splenic red pulp. Broadly defined, the term hypersplenism refers to sequestration and/or destruction of blood cells occurring in an enlarged spleen, associated with peripheral anemia and/or neutropenia and/or thrombocytopenia. In experimental animals with splenomegaly induced by methyl cellulose injections, there is accelerated destruction of normal erythrocytes. However, under conditions where macrophages are activated, there may be increased red cell destruction, and this may explain the accelerated hemolysis commonly seen with infections, in particular with malaria. March hemoglobinuria March hemoglobinuria is an unusual hemolytic disorder in which transient hemoglobinemia and hemoglobinuria develop in susceptible individuals after strenuous exercise that involves forceful contact of the body with a hard surface. Although red cell fragmentation is not always evident, the condition carries all the hallmarks of acute intravascular hemolysis, which presumably results from the mechanical disruption of circulating red cells. Occasionally, symptoms include nausea; vague abdominal, back, or thigh pain; or a burning feeling in the soles of the feet. Hemoglobinuria characteristically occurs immediately after exercise and lasts for only a few hours. March hemoglobinuria most commonly affects athletes at the beginning of a running career or on resumption of road training. The urine contains hemoglobin; after recurrences, it also may contain hemosiderin. Long-distance runners may develop iron deficiency attributable to hemosiderinuria, although the possibility of exercise-associated gastrointestinal bleeding in long-distance runners must also be considered. Thus, one postulate was that susceptible individuals destroy red cells in the soles of their feet while running. Confirmation came from the ingenious experiments of Davidson, who inserted polyvinyl tubes containing blood into the running shoes of susceptible individuals and showed that these runners destroyed their own and the control blood at about the same rate, and to a greater degree than control subjects running on the same surface. Attacks may be prevented by wearing shoes with more resilient soles and by changing to a less traumatic running style. Banfi and colleagues have reported that Liver Disease Anemia in liver disease has many causes including hemolysis (Chapter 41). One component of this shortened red cell survival relates to portal hypertension and associated splenomegaly. However, the hemolysis occurring under these conditions is usually mild, with varying degrees of a compensatory increase in red cell production. Another cause of hemolysis in liver disease is associated with the formation of "spur cells," a variant form of acanthocytes. As a consequence, they become rigid and nondeformable, and are rapidly cleared by the reticuloendothelial system, in particular the spleen351,352 (see Chapter 41). Attempts to correct portal hypertension have utilized angiographic techniques to create a communication between the intrahepatic portal vein and the hepatic vein. Anemia also ChaPtEr 32 Acquired Nonimmune Hemolytic Disorders is a frequent complication of primary renal disease, the most common cause being due to impaired erythropoietin production (Chapter 41). However, in some cases there also is a hemolytic component 354,355 that is thought to be a consequence of uremia. Classic cross-transfusion studies demonstrated that normal erythrocytes have a shortened survival in uremic patients, whereas red cells from uremic patients survive normally when transfused into healthy control individuals. Invasion of erythrocytes by Plasmodium falciparum malaria parasites: evidence for receptor heterogeneity and two receptors. Mechanisms of erythropoiesis inhibition by malarial pigment and malariainduced proinflammatory mediators in an in vitro model. The bone marrow in human cerebral malaria: parasite sequestration within sinusoids. Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods. Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia. Hematological and serological aspects of Mediterranean kala-azar in infancy and childhood. Clostridial sepsis with massive intravascular hemolysis: rapid diagnosis and successful treatment. Haemolytic anaemia in association with Escherichia coli O157 infection in two sisters. The acute infection-associated hemolytic anemia of childhood: immunofluorescent detection of microbial antigens altering the erythrocyte membrane. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hemolysis due to inadvertent hemodialysis against distilled water: perils of bedside dialysate preparation. Hemolytic anemia and multiorgan failure associated with localized cutaneous lesion. Severe and fatal mass attacks by "killer" bees (Africanized honey bees-Apis mellifera scutellata) in Brazil: clinicopathological studies with measurement of serum venom concentrations.

Disorders of the respiratory tract medicine lake buy bimat from india, particularly allergic asthma and rhinitis medications used to treat bipolar discount generic bimat canada, exhibit a strong correlation with the number as well as activation status of infiltrating tissue eosinophils symptoms joint pain and tiredness generic 3 ml bimat otc. Similarly medicine with codeine cheap bimat 3 ml buy on-line, many disorders of the gastrointestinal system exhibit prominent eosinophilic inflammation in the mucosa medicine 802 3 ml bimat purchase otc. The presence of eosinophils in the airway and gut mucosa has been associated with both allergic (IgE-dependent) and nonallergic (IgE-independent) manifestations of disease. Although clinically these conditions have been characterized as either allergic or nonallergic, it appears that the mechanisms underlying recruitment and activation of eosinophils in both types of disease are similar. Despite some difficulties in defining the exact immunologic role of the eosinophil in disease, there is evidence that the eosinophil remains a major effector cell in many types of allergic and nonallergic inflammation. Eosinophils are mobile, terminally differentiated granulocytes that arise principally from the bone marrow. The eosinophil is characterized by large crystalloid granules, also known as secondary or specific granules, as shown in light microscopy by their bright red staining properties with acidic dyes such as eosin. As apparent in electron micrographs, the crystalloid granules contain electron-dense crystalline cores surrounded by an electron-lucent granule matrix. Eosinophils contain up to four other "granule" types: primary granules, small granules, lipid bodies, and small secretory vesicles. Crystalloid granules are membrane-bound and contain a number of highly cationic basic proteins. The latter have been implicated in the tissue damage observed in asthma and other similar allergic conditions. Allergen and parasite-induced eosinophilia have been shown to be T-cell­dependent and are mediated by soluble factors (cytokines) released from sensitized lymphocytes. Some authors refer to immature crystalloid granules as primary granules in eosinophil promyelocytes. Lipid bodies: there are around five lipid bodies per mature eosinophil, the number of which increase in certain eosinophilic disorders, especially in idiopathic hypereosinophilia. Lipid bodies are enriched in arachidonic acid esterified into glycerophospholipids. Secretory vesicles: eosinophils are densely packed with small secretory vesicles in their cytoplasm. These vesicles appear as dumbbell-shaped structures in cross-sections, and contain albumin, suggesting an endocytotic origin. Photomicrograph of a peripheral blood eosinophil stained with May-grünwald-giemsa. De novo-synthesized lipid mediators and oxidative metabolites are elaborated directly from the cell membrane or lipid bodies following enzyme activation, while granule-derived cationic proteins and cytokines, chemokines, and growth factors are released following granule­plasma membrane fusion during degranulation. A list of these and other granule proteins synthesized and stored in eosinophils is presented in Table 8. This membrane-bound organelle is a major site of storage of eosinophil cationic granule proteins as well as a number of cytokines, chemokines, and growth factors. It is also antiviral, bactericidal, promotes degranulation of mast cells, and is toxic to helminthic parasites. This may be Human eosinophils have been shown to produce at least 30 different cytokines, chemokines, and growth factors (Table 8. Although many eosinophilderived cytokines are elaborated at lower concentrations than other leukocytes, eosinophils possess the ability to release these cytokines immediately (within minutes) following stimulation. After docking, the granule and plasma membrane fuse together and form a reversible structure called the fusion pore, which is also thought to be regulated by similar, or the same, membrane-associated proteins regulating granule docking. Depending on the intensity of the stimulus, the fusion pore may either retreat, leading to re-separation of the granule from the plasma membrane, or it may expand and allow complete integration of the granule membrane into the plasma membrane as a continuous sheet. The inner leaflet of the granule membrane becomes outwardly exposed, and the granule contents are subsequently expelled to the exterior of the cell. The first is the classical sequential release of single crystalloid granules, which was the original hypothesis suggested for a predominant route of degranulation in eosinophils. This type of release is typically seen in vitro and can be elegantly demonstrated electrophysiologically using patch-clamp procedures that measure changes in membrane capacitance, which are directly proportional to increases in the surface area of the cell membrane. The yellow color in (B) resulted from co-localization of green and red immunofluorescence stains. B the normal hematologic system sequential release of individual crystalloid granules, a stepwise increment in capacitance may be observed as their membranes fuse with that of the cell membrane. Degranulation responses to immobilized stimuli have been extensively characterized in eosinophils in view of their role in helminth infections. When incubated with opsonized helminths, eosinophils degranulate onto the surface of the parasite. The most commonly observed forms of degranulation in allergic disease are piecemeal degranulation and necrosis (cytolysis). Parasitic and fungal diseases typically exhibit eosinophils undergoing compound exocytosis. Eosinophils also degranulate in response to cysteine proteases such as those from cockroaches and Der f 1 from mite allergens. This molecule has multiple roles in eosinophils; it is not only important in eosinophil adhesion and recruitment but also for activation of eosinophil effector functions. Integrins and especially Mac-1, play a crucial role in eosinophil activation by immobilized stimuli such as IgG. Moreover, Mac-1 can directly recognize fungal molecules such as b-glucan, and eosinophils react by degranulation to fungi through this mechanism. These three molecules form a stable detergent-resistant four-helix coiled-coil bundle, which may be regulated by protein phosphorylation. A fascinating study has identified a hitherto unrecognized functional capacity for eosinophil granules that have been cytolytically released extracellularly (cell-free), a phenomenon known to occur in vivo. These include receptors for IgA, IgD, IgE, IgG, and IgM, which may possess up to three chains (a, b, and g). Mucosal tissues are enriched in sIgA, potentially as a mechanism against invasive pathogens. Thus, the sensitivity of the eosinophil to IgA is in agreement with its proposed role in protection against invasive organisms in mucosal tissues. Taken together, these findings along with eosinophil localization in mucosal tissues suggest an important role for sIgA and IgG in mediating the effector functions of eosinophils in vivo. These are produced by microbes and are also present in various allergens, including house dust mites, fungi, and cockroaches. Schematic model for molecular regulation of granule­plasma membrane fusion proposed to occur in piecemeal degranulation in eosinophils. Stimulating cell-free granule receptors resulted in activation of intragranular signaling pathways, which in turn, elicited secretion of cytokines and cationic proteins from within granules. Such observations have implications for the notion that tissue-discharged, intact eosinophil granules may continue to contribute to eosinophil-mediated inflammation and immunomodulation. Mechanisms associated with granule release in eosinophils are critical for effector function of eosinophils. In the absence of degranulation and mediator secretion, the eosinophil is a relatively inert cell, and does not affect surrounding tissues, as seen in cases of idiopathic pulmonary eosinophilia and eosinophilic pneumonia. In these conditions, eosinophil numbers are increased in the capillaries and tissues of the lung, but no cellular or structural damage is evident, likely because of the lack of eosinophil degranulation. In contrast, asthmatic patients show profound eosinophil activation in the airways combined with significant tissue destruction, suggesting that, in addition to eosinophilic infiltration, their undergoing degranulation may contribute to mucosal damage in the airways and related symptoms of asthma. Membrane-derived Mediators Eosinophils produce a wide variety of lipid-derived mediators, which have profound biologic activity. Substrates include arachidonic acid, linoleic acid, polyenoic acids, and more complex lipids, such as lipoproteins. The immune function of respiratory burst is to mediate killing of invasive pathogenic microorganisms; it also has the undesired effect of collateral tissue damage when dysregulated. This complex is essential for the inducible release of superoxide for microbicidal reactions and is also present in neutrophils. Rac1 is ubiquitously expressed throughout the body, whereas neutrophils, eosinophils, and other blood cells predominantly express Rac2, which is mainly expressed in hemopoietic tissues. Taken together, eosinophils generate substantial amounts of O2-· as part of their role in host defense, and the mechanisms associated with the release of this toxic mediator are under investigation. The release of O2-· from eosinophils is likely to be a crucial component of the pathophysiologic processes underlying eosinophilic inflammation in mucosal tissues. To determine the involvement of eosinophil-derived factors in modulating the immune response, the expression and bioactivity of cytokines released from eosinophils have been explored for their potential physiologic effects in immune regulation. Generally speaking, eosinophils produce significantly smaller amounts of cytokines than T-cells, B-cells, and other cells. However, in eosinophilic inflammation, eosinophils outnumber T-cells in the tissues by as much as a hundredfold. As such, the magnitude of the presence of eosinophils may be a determining factor in regulating immune responses at a local level. The release of eosinophil cytokines often takes place within a much shorter period than cytokines released by T-cells (which may be several hours), as eosinophil-derived cytokines are stored as pre-formed mediators in crystalloid granules and may be secreted in response to stimuli in a matter of minutes. The production of cytokines by eosinophils is postulated to contribute to an immunoregulatory role by these cells, and may promote an allergic phenotype by influencing the production of Th2 cytokines by T-cells. Allergy is often characterized by a significant polarization of the immune response toward enhanced production of Th2 cytokines and a dramatic increase in allergen-specific and total immunoglobulin E (IgE) levels. These cytokines are crucial for the maturation, proliferation, survival, and activation of mast cells, basophils, and eosinophils, important effector cells. Th2 cytokines also regulate IgE synthesis by B-cells and mucus production by epithelial cells. The immunologic responses of eosinophils are dependent on an array of cytokines and chemokines that may traditionally be associated with Th1 or Th2 responses. Eosinophils synthesize many of these cytokines and chemokines to which they can also respond. Based on their ability to synthesize, store, and release both Th1 and Th2 cytokines and chemokines, and significant evidence indicating the bioactivity of their released cytokines, eosinophils have been implicated as active components of allergic disease, rather than as bystander cells. Classically, the Th1 response has been modeled as an immune response that exerts inhibitory effects on Th2 responses. It is therefore paradoxical that eosinophils, as a cell type marking Th2-type responses to allergic diseases or helminthic infections, synthesize and store both Th1 and Th2 cytokines (see Table 8. These eosinophils are anatomically localized within specific compartments of the thymus coinciding with negative selection of double-positive thymocytes. Indeed, abundant numbers of eosinophils were detected in human thymus tissue in infants ranging between the ages of 2 weeks to 12 years undergoing open-heart surgery for congenital cardiac disease. Eosinophils constituted 2% of total thymic cell count post-natally; the counts were shown to be highest during the early stages of life and declined with age. The latter were suggested to play a major role in regulatory T-cell (Treg) differentiation via the epithelial lining of these corpuscles. This has potential relevance for the development of early-in-life immune response patterns especially in regard to polarization of the immature immune system. These observations may have significant relevance for the role of the eosinophil in health and disease. Eosinophils are also likely to play a role in long-term maintenance of bone marrow plasma cells, inasmuch as plasma cell numbers were decreased in the bone marrow of eosinophildeficient mice; a defect that was reversed by eosinophil reconstitution. Apart from these, other eosinophil-derived immunoregulatory factors have been recently recognized. The role of eosinophil-derived Th1 or Th2 cytokines may therefore depend on the timing of eosinophil infiltration into sites of allergic inflammation. A proposed scheme addressing an immunoregulatory role that the eosinophil may play in asthma and allergy. Eosinophils have the capacity to exert powerful effector functions against mucosal tissues that may contribute to airway hyperresponsiveness. However, the full capacity of the eosinophil to elaborate cytokines, the precise microenvironment requirements for such synthesis, the intracellular pattern of production and storage, including the timing of its immunomodulatory function during immune responses, remain the subject of intensive investigation. Eosinophils make up approximately 3% of the bone marrow from healthy individuals, of which 37% is fully differentiated, and the remainder is promyelocytes/myelocytes and metamyelocytes. Cytokines derived from eosinophils may lead to autocrine prolongation of eosinophil maturation and survival in tissues. Extracellular matrix proteins have been shown to modulate eosinophil responses to soluble physiologic stimuli. These receptors function to enhance eosinophil responses and are likely to promote the activation of tissue eosinophils by cytokines and other signaling molecules. Tyrosine phosphorylation enhances the expression of the antiapoptotic protein Bcl-xL in eosinophils, and decreases translocation of the proapoptotic signaling molecule Bax, resulting in decreased activation of apoptotic signaling through the caspase family. Thus, the growth, maturation, and prolongation of survival of eosinophils in extramedullary tissues may occur in sites other than the bone marrow. The half-life of eosinophils in the circulation is approximately 18 hours with a mean blood transit time of 26 hours,231 although this is extended in eosinophilic conditions, possibly due to the elevation of systemic eosinophil-activating cytokines that promote eosinophil survival. Based on a study of 740 medical students, the normal range of blood eosinophils was shown to be between 0 and 0. Allergy is commonly associated with eosinophilia in the mild range, whereas parasitic infestation is often characterized by a marked eosinophilia. Eosinophils are predominantly tissue cells, and their major target organs for homing in the healthy individual is the gastrointestinal tract (outside of the esophagus), mammary gland, uterus, thymus, and bone marrow. The gastrointestinal tract is the predominant site of homing for tissue eosinophils in healthy humans. Once they enter target tissues, eosinophils do not return to the blood circulation. Eosinophil numbers can remain high in tissues even when peripheral numbers are low, suggesting that their survival is enhanced upon extravasation. Curiously, pathogen-free laboratory animals have no eosinophils in their blood, and tissue eosinophils are scarce, suggesting that the appearance of eosinophils may be environment- or disease-related. There are three different populations of eosinophils that can be characterized based on their intrinsic buoyant density and responsiveness to stimuli. These are the normodense, hypodense, and primed eosinophils, which can be described in both normal and eosinophilic subjects.

Purchase genuine bimat on line. POST STREPTOCOCCAL GLOMERULONEPHRITIS Causes Signs and Symptoms Diagnosis and Treatment..

The resulting oligonucleotides are probably further degraded by phosphodiesterases and phosphatases to pyrimidine nucleotides symptoms vs signs purchase bimat online now. A specific pyrimidine 5-nucleotidase found in reticulocytes dephosphorylates these nucleotides treatment uterine cancer purchase 3 ml bimat amex, and the free pyrimidine bases can then leak out of the cell symptoms stroke buy discount bimat. As detailed in the previous section medications 377 order generic bimat on-line, many of the morphologic criteria used in staging the maturation of erythrocyte precursors are related to hemoglobin production and content medicine quiz cheap bimat 3 ml buy line. In most human populations, the a genetic locus is duplicated, and there are four (two pairs of) identical a genes in normal subjects. The a-gene cluster (approximately 30 kb) is located on the short arm of chromosome 16 and also contains the locus encoding for the z-chain,78 while the b-gene cluster (approximately 50 kb) is located on chromosome 11 and includes the genes for the Gg-, Ag-, d-, and â-globins. The differentiation of erythroid progenitors to erythroblasts is accompanied by the activation of the genes involved in erythroid differentiation, including the globin genes. Solid areas within genes represent coding sequences; open areas represent intervening sequences. Each cluster includes pseudogenes (z, a, b), which have sequence homology to functional genes but include mutations that prevent their expression. Porphyrins are heterocyclic organic rings composed of four pyrrole subunits that are usually linked by methine bridges; their conjugation to diverse divalent metal ions such as Mg2+, Co+, and Fe2+ gives rise to the "pigments of life," i. It serves as a critical component of hemoproteins, including cytochromes (for mitochondrial respiratory chain electron transfer and drug metabolism), oxidases. Note that the product of step 2 is the monopyrrole porphobilinogen, the primary building block for all natural tetrapyrroles, including hemes, chlorophylls, and the vitamin B12 derivatives (cobalamins). How the heme synthesis intermediates are transferred from one cytosolic enzyme to the next in the pathway is at present unknown, but a macrocomplex comprising all four cytosolic enzymes, as has also been proposed for the terminal pathway enzymes, may occur. At the periphery of the tetrapyrrole are eight sites where side chains are located. In heme, the iron atom is inserted "like a gem"105 into the center of the tetrapyrrole. They are very stable, essentially flat molecules and the macrocyclic ring itself has little or no affinity for water. All porphyrins are intensely colored and they have an extremely intense absorption band at approximately 400 nm, the so-called Soret band. All porphyrins fluoresce, but fluorescence is characteristically lost when metals are bound to form metalloporphyrins. Exceptions include Mg-porphyrins and Zn-porphyrins, which fluoresce despite their metal content (Chapter 26). Of the known porphyrins, five are of importance in humans: uroporphyrin (two isomers), coproporphyrin (two isomers), and protoporphyrin (one isomer). These latter compounds are colorless, do not fluoresce, cannot bind metal ions, and are extremely unstable with regard to oxidation. If uroporphyrinogen or coproporphyrinogen (intermediates in heme biosynthesis) are oxidized to their corresponding porphyrins, they can no longer function as substrates for the heme biosynthetic enzymes and must eventually be excreted in the urine and stool. Uroporphyrinogen I and coproporphyrinogen I are useless by-products of heme synthesis (see Chapter 26). Once formed, most uroporphyrinogen I is enzymatically decarboxylated to coproporphyrinogen I and excreted as the oxidized compound, coproporphyrin I. In the type I isomer, the 7 and 8 positions are occupied by acetate and propionate, respectively. As there is no translation initiation site in exon 1, however, identical transcripts are generated. It is also active in mature circulating erythrocytes, even though these cells are not actively synthesizing heme. The mammalian enzyme is an octamer of 31 kDa subunits containing zinc atoms required for stability and activity. Within a few hours, a solution of porphobilinogen exposed to air and light develops a deep orange-red color. The color results from the formation of porphobilin, a poorly defined mixture of mono-, di-, and tripyrrolic oxidation products. If instead porphobilinogen is incubated in solution at an acid pH then nonenzymic condensation or cyclization occurs, forming the tetrapyrrole macrocycle uroporphyrinogen. The reaction is often referred to as a "head-to-tail" condensation because of the apparent orientation of the precursor molecules. The exact location of coproporphyrinogen oxidase in the mitochondria is unknown, with studies suggesting it is present in the intermembranous space and/or loosely associated with the inner surface of the outer membrane. The enzyme, which has a long mitochondrial targeting sequence, functions as a dimer and has an absolute requirement for molecular oxygen. The gene encoding coproporphyrinogen oxidase is located at 3q12, contains seven exons and spans 14 kb. Although the in vivo substrates are ferrous iron and protoporphyrin, in vitro, the enzyme can also catalyze incorporation of several metals (iron, cobalt, and zinc) into several dicarboxylic porphyrins (protoporphyrin, mesoporphyrin, and deuteroporphyrin). Apart from its use for heme synthesis, mitochondrial iron is also required for mitochondrial Fe-S cluster biogenesis. Fe-S clusters are modular protein co-factors consisting of iron and sulfur, usually linked by bonds joining the cysteine sulfur atoms of a polypeptide ("scaffold") protein to iron atoms of the cluster. Recent analyses of mass cultures of erythroid progenitors indicate that, with differentiation, these cells behave as if a "low cytosolic iron level" condition exists. Regulation of erythroid heme involves the induction of the enzymes of the heme biosynthetic pathway and their regulation once induced,105,107 regulation of iron uptake and its delivery to ferrochelatase in the mitochondria, and the regulated export of the newly formed heme from the mitochondria to the cytosol to bind to globin chains. Thus, it is the supply of iron to the erythroid precursor that ultimately controls heme synthesis. To allow maximal heme synthesis-which requires 20 mg of iron for the 20 g of erythrocytes generated in adult humans every day-iron is delivered to the bone marrow in the form of ferric-transferrin (Fe-Tf) that is rapidly bound by TfR1 present in large numbers on the cell surface of erythroid precursors (up to 106 receptors per cell178). By necessity, there must also be upregulation of an unidentified heme transporter to export heme from the mitochondria into the cytosol. As a feedback mechanism "uncommitted" or "free" heme appears to inhibit either Fe-TfTfR endocytosis or iron release from Tf to prevent unnecessary iron uptake. Although each component is essential for hemoglobin synthesis, individually they are all potentially cytotoxic and it is therefore crucial that the a- and b-globin chains and heme are produced in the 2:2:4 ratio necessary to form the stable complex of a2b2 and 4 heme molecules that comprise hemoglobin A. Studies of the hri knockout mouse verify the importance of this protective mechanism during high-level hemoglobin synthesis. The impairment in differentiation is also observed upon conditional deletion of flvcr1 in neonatal mice,187 who develop a severe anemia within 5 weeks of deletion187 that may be due to erythroid cell apoptosis. Alterations in the concentration of hemoglobin in the blood lead to changes in tissue oxygen tension within the kidney. This hormone induces differentiation of erythroid progenitor cells, expansion of the erythroid marrow, and increased red cell production. This, in turn, leads to an increase in the size of the erythron and an increase in tissue oxygen levels. The major steps in this process are discussed in greater detail in the sections that follow. The Normal Hematologic System Tissue Oxygen Tissue oxygen tension depends on the relative rates of oxygen supply and demand. Oxygen supply is a complex function of interacting but semi-independent variables, including (a) blood flow, (b) blood hemoglobin concentration, (c) hemoglobin oxygen saturation, and (d) hemoglobin oxygen affinity. Each of these functions may be altered to compensate for a deficiency in one of the others. For example, in severe anemia, cardiac output and respiratory rate may increase, and hemoglobin oxygen affinity may be reduced through the 2,3-biphosphoglycerate effect. Despite cardiovascular and respiratory adjustments, tissue oxygen tension decreases roughly in proportion to the degree of anemia. Conversely, induced polycythemia of moderate degree leads to normal or increased tissue oxygen tension and an increased tolerance to hypoxia. These changes occur despite the increase in blood viscosity that accompanies polycythemia, suggesting that peripheral vascular resistance decreases to compensate for increased viscosity. However, with advanced degrees of polycythemia, the increase in viscosity may be great enough to negate the advantages of increased oxygen-carrying capacity. Tissue hypoxia is the fundamental stimulus to erythropoiesis, as first suggested by Miescher in 1893. The nature of the tissue oxygen receptors (or oxygen sensor) has only recently been understood. These sensors are located within the kidney and Epo production can be induced by renal artery constriction or by hypoxic perfusion of the isolated kidney. The bulk of experimental evidence indicates that these are fibroblast-like type I interstitial cells. The number of interstitial renal Epo-producing cells increases (approximately exponentially) in response to anemia, indicating that increased Epo production is met by an increase in the number of Epo-producing cells; presumably with worsening anemia, increased numbers of these cells become sufficiently hypoxic to trigger Epo synthesis. Epo and EpoR are also expressed at low levels in other tissues including the spleen, bone marrow, lung, testis, eye, and brain. A sequence located in a region flanking the 3 end of the Epo gene is oxygen-sensitive and involved in regulation of expression. The hormone was originally purified from the urine of patients with aplastic anemia. Asialated Epo and nonglycosylated rEpo produced in bacteria have no activity in vivo, which is at least partially attributed to rapid clearance of the hormone by the liver via hepatocyte galactose receptors. For example, the gene has been modified by adding a second site of N-linked glycosylation, such that when the gene is expressed in Chinese hamster ovary cells, the amount of carbohydrate attached to the modified protein is almost doubled. This new product, called darbepoetin, has a longer in vivo half-life than rEpo, thus fewer injections per week are required for therapeutic efficacy. Two Epo-EpoR binding sites on Epo have been identified, a high-affinity site 1 (Kd 1 nM) and low-affinity site 2 (Kd 1 mM). Site and Regulation of Erythropoietin Production More than 50 years ago Jacobson et al. Deletion of either of the genes encoding for Epo or EpoR in mice results in the identical phenotype of fetal death at embryonic days E11. EpoR is expressed on hematopoietic cells that respond to Epo and has been identified on human12 and murine erythroid cells,216 on erythroleukemia cell lines,216 in murine fetal liver tissue rich in erythroid elements, in mouse and rat placenta,217,246 and on megakaryocytes. The presence of EpoR on megakaryocytes246­248 explains why Epo at physiologic concentrations promotes megakaryocyte differentiation and can thus affect platelet levels. Receptors for Epo are also observed on nonhematopoietic tissues including neurons and cardiac myocytes, endothelial cells, the kidneys, and embryonic muscle. Tyrosine phosphorylation of the EpoR262 is the first observable event after Epo binding. Because EpoR lacks a kinase domain, a tyrosine protein kinase must therefore associate with the receptor. Interestingly, recent studies indicate that the activation of EpoR through binding of Epo initiates a scissorlike rotation of the EpoR dimers, separating the intracellular domains of the two receptor molecules to allow room for the associated Jak2 molecules; in addition there appears to be a self-rotation of each monomer to allow them to orient properly for transphosphorylation of Jak2. The activated kinases phosphorylate all eight conserved tyrosine residues of the EpoR cytoplasmic tail. Conformational changes in EpoR dimers induced by Epo binding facilitate the activation of EpoR-associated Jak2 kinases. Jak2 kinase activation results in phosphorylation of several tyrosines in the EpoR cytoplasmic tail that then serve as docking sites for signaling or adaptor proteins containing phosphotyrosine-binding domains. The signaling proteins become phosphorylated and function in numerous downstream signaling cascades. This kinase regulates cell-cycle, cell differentiation, and pro-survival pathways and modulates metabolism and protein translation. Two recent studies of Bcl-xL­deficient animals confirmed Bcl-xL expression is required for normal erythropoiesis, but also demonstrate that it promotes the survival of mature erythroid cells that no longer depend on Epo for survival. In addition, knockdown of the Src family tyrosine kinase Lyn results in attenuated EpoR signaling and decreased erythroid precursor survival. Of interest, recent studies indicate that polymeric IgA (pIgA1­oligomers of IgA joined by their J-chains), produced in small amounts by plasma cells, binds to TfR1 present on the erythroblast cell surface. As is found with other cell signaling cascades there is a need for checks and balances in the form of inhibitory or regulatory factors, to prevent overstimulation of erythroid cells by Epo/ EpoR-mediated growth and survival signals. These cells express the highest density of EpoR on their cell surface and are absolutely dependent on Epo for survival. One of the most impressive effects of Epo is the ability of the hormone to maintain the viability of erythroid cells irrespective of any effect on cycling and differentiation. These findings suggest that the hormone promotes erythroid differentiation simply by allowing cell survival. Similarly, once the red cell mass is restored to normal, the ensuing decrease of Epo levels leads to a rapid turn-off of erythropoiesis by allowing programmed cell death to occur. Thus, neither Epo nor receptors for Epo are necessary for the proliferation and differentiation of stem cells and early progenitor cells into relatively mature erythroid cells. These studies would suggest that Epo-induced survival allows cell-autonomous terminal erythroid differentiation. Historically, Epo was detected by the polycythemic mouse assay in which the serum sample was injected with 59Fe into polycythemic mice and the amount of 59Fe incorporated into newly released red cells was measured. The immunoassays have the advantages of being quick, accurate, relatively inexpensive, and capable of quantifying very low Epo levels ordinarily not detectable by bioassays. Normal serum Epo levels, although variable with the type of assay, usually range between 5 and 30 mU/ml. An inverse correlation has been established between the logarithm of serum Epo concentration and the concentration of hemoglobin in the blood324,327; however, the magnitude of the increase in the serum Epo concentration in response to anemia is variable among individuals. A disadvantage of the immunoassays is that they detect immunoreactive but not necessarily bioactive hormone.

Shear forces in the circulation likely contribute to the cleavage of barbell-shaped proplatelets into individual platelets medications made from animals purchase 3 ml bimat fast delivery, although it has been postulated that mechanisms similar to those driving cell separation in cytokinesis may also be involved symptoms jaw bone cancer discount 3 ml bimat with visa. Programmed cell death represents not only the end of the megakaryocyte life cycle and proteins that regulate the intrinsic apoptosis pathway influence megakaryocyte survival medicine measurements bimat 3 ml with mastercard. Apoptosis has also been proposed to play a role in megakaryocyte functions such as proplatelet formation medications metabolized by cyp2d6 order cheapest bimat. Early studies found that focal activation of caspases accompanies megakaryocyte maturation and overexpression of Bcl2 inhibits proplatelet formation treatment tmj bimat 3 ml buy fast delivery, suggesting that localized apoptosis is required for platelet shedding. In mouse models, targeted loss of Bcl-xL in megakaryocytes leads to caspase activation and failure of proplatelet formation and release of morphologically abnormal, large platelets. Mutation or pharmacologic inhibition of Bcl-xL leads to reduced platelet life span in mice. As cells start to differentiate, lineage-specific transcription factors promote their own expression while suppressing factors that would favor other cell types, thus reinforcing lineage choice. Genes next to regions bound by all five factors were highly enriched for known regulators of megakaryocytic differentiation or function. Mutant forms of several of these factors or their downstream targets have been found in inherited thrombocytopenia syndromes or leukemias. Scl/Tal1 directly binds regulatory elements of Mef2C in megakaryocytic cells, and the platelet phenotype of Mef2C- knockout mice is similar to that of Scl/Tal1-deficient animals. In mouse models, loss of Fli1 suppresses megakaryopoiesis, whereas overexpression of Fli1 promotes megakaryocyte development while suppressing erythropoiesis. In megakaryocytes, miR155 expression is reduced as cells differentiate toward megakaryocytes, and overexpression of miR-155 inhibits megakaryopoiesis in in vitro and mouse models, potentially by targeting Meis1 and Ets1 transcripts. Down-regulation of c-Myb promotes megakaryocytic differentiation at the expense of erythroid cells. Genetic elimination of c-mpl or tpo in mice leads to profound thrombocytopenia due to a greatly reduced number of megakaryocyte progenitors and mature megakaryocytes and the reduced polyploidy of the remaining megakaryocytes. ChaPtEr 15 Megakaryocytes are highly related,301,302 and the receptors for the two cytokines share a common subunit. Notch signaling is initiated when the extracellular portion of a Notch receptor binds one of its cognate ligands, resulting in proteolytic cleavage that releases the intracellular domain of Notch from the membrane, allowing it to translocate to the nucleus and stimulate gene transcription. Although previously recognized for its role in T-cell development, Notch has more recently been shown to specify megakaryocyte development from hematopoietic stem and progenitor cells. The extracellular domain is N-glycosylated, enhancing receptor secretion and cell surface expression. As should be clear from the previous discussion, the megakaryocyte (and probably all hematopoietic cells) uses multiple molecular pathways to affect cell survival and proliferation. Recent work with c-Mpl has helped to clarify the nature and teleology behind this seeming redundancy. As discussed above, following initiation of signaling, the ligated c-Mpl is internalized and degraded. In the absence of Lnk, mice exhibit thrombocytosis and over time develop a myeloproliferative disorder. Akt is a serine-threonine kinase with multiple targets that have roles in cell survival and growth. Additional skeletal and nonskeletal defects are frequent, including lower extremity, cardiac, renal, and gastrointestinal abnormalities. The major complication of this disorder is not bleeding but the development of myelodysplasia or leukemia. Granule Disorders: the study of disorders involving platelet a-granules (gray platelet syndrome) or dense granules (Hermansky Pudlak syndrome) has provided insights into the cellular mechanisms involved in granule formation in the megakaryocyte. In Hermansky Pudlak syndrome, defects in the biogenesis and trafficking of lysosome-related organelles, including melanosomes and platelet dense granules, underlie the hypopigmentation and bleeding manifestations characteristic of the disorder. The mutation Ser505Asn within the transmembrane domain of c-Mpl was identified in a large Japanese family with thrombocytosis, and the mutant c-Mpl was shown to confer cytokine independence in a Ba/F3 cell line. Although inheritance is X-linked, a mild phenotype due to skewed X-inactivation in female family members has been described. This disorder resembles type 2B von Willebrand disease and is called platelet-type von Willebrand disease. Although it is not yet certain whether this molecular arrangement has physiologic consequences. Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Characterization of a bipotent erythromegakaryocytic progenitor in human bone marrow. Endomitotic megakaryocytes that form a bipolar spindle exhibit cleavage furrow ingression followed by furrow regression. Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling. Role of RhoA-specific guanine exchange factors in regulation of endomitosis in megakaryocytes. Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis. Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. Mechanisms of organelle transport and capture along proplatelets during platelet production. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function. Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Control of thrombopoietininduced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Two patterns of thrombopoietin signaling suggest no coupling between platelet production and thrombopoietin reactivity in thrombocytopenia-absent radii syndrome. Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. FlnA-null megakaryocytes prematurely release large and fragile platelets that circulate poorly. Platelet-type von Willebrand disease: a rare, often misdiagnosed and underdiagnosed bleeding disorder. Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain. An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. A lineage-restricted and divergent betatubulin isoform is essential for the biogenesis, structure and function of blood platelets. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Notch signaling specifies megakaryocyte development from hematopoietic stem cells. This channel system is involved in the regulation of intracellular calcium transport because it has been reported to selectively bind, sequester, and release divalent cations after activation. By scanning electron microscopy, circulating resting blood platelets appear as flat discs with smooth contours, rare spiny filopodia. Initial descriptions of platelet anatomy stem from studies employing transmission electron microscopy; and platelet structure is classified into four general areas: the platelet surface, membranous structures, cytoskeleton, and granules. Dense tubules Platelet Surface the platelet plasma membrane separates intra- from extracellular regions and, in thin sections, exhibits a typical 20-nm-thick trilaminar structure5 whose overall appearance does not differ from that of other blood cells. Platelets, indicated by arrows, are interspersed between erythrocytes and a few leukocytes. These varied functions are performed by three distinct structures: first, the membrane skeleton, which buttresses the inner side of the plasma membrane; second, the mass of actin and intermediate filaments, which fills the cytoplasm; and third, the circumferential microtubule band, which encircles the substance of the platelet to produce the resting disclike form. The membrane skeleton was first described more than 30 years ago by electron microscopy36,37 and then analyzed biochemically by detergent lysis in Triton X-100. Many surface indentations, indicated by arrows, are present; these correspond to openings of the surface-connected canalicular system to the external milieu. Optimal techniques for the immunocytochemical demonstration of b-thromboglobulin, platelet factor 4, and fibrinogen in the alpha granules of unstimulated platelets. Morphologically, platelets rapidly lose their discoid shape, become rounded, and extend filopodia. Diagram of a human platelet displaying components visible by electron microscopy and cytochemistry. In addition to membranous components (plasma membrane, surface-connected canalicular system, and dense tubular system), mitochondria, microtubules, and glycogen, four types of storage organelles are identified: a-granules, dense bodies, lysosomes, and microperoxisomes. Whereas the first two can be identified morphologically, microperoxisomes and lysosomes are recognizable only by cytochemical stains. Human platelet cytoskeletons prepared by simultaneous fixation and lysis in Triton X-100 detergent. Single actin filaments, indicated by short arrows, course throughout the platelet cytoplasm. Organization of the cytoskeleton in resting, discoid platelets: preservation of actin filaments by a modified fixation that prevents osmium damage. A circumferential microtubule band that supports the discoid form of the platelet33,34 is made of two nonidentical subunit proteins (a- and b-tubulin), associated with microtubule-associated proteins. The 25-nm-diameter microtubule coil lies adjacent to , but does not touch, the plasma membrane. Platelet activation results in microtubule disassembly and then reassembly; such alterations in the marginal microtubule bundle result in platelet shape changes. Platelet granule structures include a- and dense granules, lysosomes, and peroxisomes. The larger, electron-dense region is often eccentrically placed and consists of a nucleoid material that is rich in platelet-specific proteins such as b-thromboglobulin. Molecular Weight 42,000 500,000 235,000 130,000 102,000 260,000 91,000 5,000 15,200 28,000 80,000 105,000 17,000 Principal Known Function Major protein constituent of microfilaments; 30% of platelet protein; F-actin binds myosin. Binds actin; phosphorylation of light chains contracts microfilaments; 4% of platelet protein. Binds 1:1 with G-actin and inhibits its polymerization; adds adenosine triphosphate. Fibrinogen is also found in a-granules, but is incorporated actively from plasma and not synthesized by megakaryocytes. How populations of angiogenesis regulatory proteins may be selectively compartmentalized and released from platelets is an area of active investigation. The platelets and megakaryocytes of patients with gray platelet syndrome have decreased numbers of a-granules and reduced levels of some proteins. It is proposed that there is incorrect targeting of a-granule proteins to the a-granule in the megakaryocyte in this disease. Note: A number of additional elements are released or secreted from within the platelet. In addition, dense granules contain guanosine triphosphate/guanosine diphosphate and high concentrations of pyrophosphate, phosphate, and magnesium, much of which is secreted with activation. Platelets contain substantial amounts of vitamin B12, folic acid, and ascorbic acid. Peroxisomes are rare, small (90 nm in diameter) granules, demonstrable with alkaline diaminobenzidine as a result of their catalase activity. There are approximately seven per human platelet, and they serve as the site for the actions of the respiratory chain and the citric acid cycle. Platelet stimulation by agents that induce aggregation and release is associated with a marked increase in metabolic activity involving glycogenolysis,124 as well as with glycolysis and oxidation to varying degrees. The platelet, like muscle, is metabolically adapted to expend large amounts of energy rapidly during aggregation, the release reaction, and clot retraction. The major energy source for the platelet is glucose, which is rapidly taken up from the plasma.

References

• Chayakulkeeree M, Ghannoum MA, Perfect JR. Mucormycosis: the reemerging fungal infection. Eur J Clin Microbiol Infect Dis 2006;25(4):215-29.
• Case CL, Gillette PC. Automatic atrial and junctional tachycardias in the pediatric patient: Strategies for diagnosis and management. Pacing Clin Electrophysiol. 1993;16:1323- 35.
• Kong J, Ma L, Gollub RL, et al. A pilot study of functional magnetic resonance imaging of the brain during manual and electroacupuncture stimulation of acupuncture point (LI-4 Hegu) in normal subjects reveals differential brain activation between methods. J Altern Complement Med. 2002;8(4):411-419.
• Cohen G, David TE, Ivanov J, et al. The impact of age, coronary artery disease, and cardiac comorbidity on late survival after bioprosthetic aortic valve replacement. J Thorac Cardiovasc Surg 1999;117:273-284.
• Gruschwitz, T., Stein, R., Schubert, J., Wunderlich, H. Laser-supported partial nephrectomy for renal cell carcinoma. Urology 2008;71:334-336.